Throughput
Fluofarma's technology keeps your project moving at high
speed throughout the R&D process. Our technology platform enables
large-scale screening programs, with 2000 wells tested a day and 2500
individual cells analyzed per well.
As shown in the Figure below, the Fluofarma HCS
technology substantially boosts the number of compounds that can be
analyzed. The more compounds you test, the more you improve your chances of
identifying a blockbuster.
Fluofarma (green) vs. Standard (red) drug
discovery process:
► With Fluofarma, understand a large number of compounds and optimize your decision making.
Breaking news
Scientific Publication
Fluofarma is glad to announce a new scientific publication in the journal Cell Research.Read more [+]
Publication
Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”Read more [+]
Press Release
Roche adopts Fluofarma’s high-content screening platform.Read more [+]
Scientific Publication
Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".Read more [+]
ECCP 2010
Fluofarma will be attending the European Cancer Cluster Partnering 2010 in Oslo, from September 15th to 17th.Read more [+]
BIO-Connexion Congress
Fluofarma will be attending the Bio-Connexion Congress in Paris, from October 6th to 7th.Read more [+]
22nd EORTC-NCI-AACR symposium
Fluofarma will be exhibitor at the 22nd EORTC-NCI-AACR symposium in Berlin from November 16th to 19th.Read more [+]